Onasemnogene abeparvovec
Orphan Drug Cold Chain RequiredNot registered in India
Contents
Description
Onasemnogene abeparvovec is a gene therapy for spinal muscular atrophy type 1. It delivers a functional copy of the SMN1 gene using an AAV9 vector.
Indications & Therapeutic Use
SMA Type 1 (pediatric patients)
Linked Diseases:
Access Programs
Named Patient ProgramNamed Patient Program
Framework: Country-specific regulatory approvals
Typical timeline: 21 days
Buy / Source Onasemnogene abeparvovec — GNH India
6 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Onasemnogene abeparvovec products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Onasemnogene abeparvovec
| Generic Name | Onasemnogene abeparvovec |
| Brands | 1 brand available |
| Active Ingredient | Onasemnogene abeparvovec-xioi |
| Drug Class | SMA Type 1 (pediatric patients) |
| Manufacturer | Novartis Gene Therapies |
| Dosage Forms | IV infusion |
| Medical Code | RxNorm:2284718 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | Not registered in India |
Authority Signals
Last Verified3/11/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations1 Validated Nodes